Karuna Therapeutics, Inc. (KRTX) Covered Calls
There are no covered calls available for Karuna Therapeutics, Inc..
Born To Sell's covered call screener gives you full search capabilities so you can find stocks and ETFs that make good covered call candidates.
Want to make money with covered calls? Sign Up For A Free Trial
Extended Business Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, primarily focuses on developing novel therapies to address disabling neuropsychiatric disorders and pain. Its lead product candidate is KarXT, an oral modulator that has completed Phase II clinical trial for the treatment of acute psychosis in patients with schizophrenia; and in Phase Ib clinical trial for the treatment of central nervous system disorders, such as negative and cognitive symptoms of schizophrenia and psychosis, Alzheimer's, and pain, as well as for the treatment of dementia-related psychosis. The company also focuses on developing other muscarinic-targeted drug candidates. Karuna Therapeutics, Inc. has a license agreement with Eli Lilly and Company; patent license agreement with PureTech Health LLC; and drug discovery partnership with Charles River Laboratories, as well as drug discovery collaboration with PsychoGenics Inc. The company was formerly known as Karuna Pharmaceuticals, Inc. and changed its name to Karuna Therapeutics, Inc. in March 2019. Karuna Therapeutics, Inc. was founded in 2009 and is headquartered in Boston, Massachusetts.
Top 10 Open Interest For Apr 19 Expiration | Top 5 High Yield | |||||
---|---|---|---|---|---|---|
1. | IWM covered calls | 6. | TLT covered calls | 1. | MRNS covered calls | |
2. | SPY covered calls | 7. | HYG covered calls | 2. | SOUN covered calls | |
3. | QQQ covered calls | 8. | AAPL covered calls | 3. | DWAC covered calls | |
4. | SLV covered calls | 9. | EEM covered calls | 4. | HUT covered calls | |
5. | FXI covered calls | 10. | TSLA covered calls | 5. | NOVA covered calls |
Want more examples? KRP Covered Calls | KRYS Covered Calls